Načítá se...
Developing idiotype vaccines for lymphoma: From preclinical studies to Phase III clinical trials
Therapeutic vaccines for B-cell non-Hodgkin lymphoma using the clonal tumor immunoglobulin idiotype, have been under development for more than three decades. A major obstacle for rapid progress in the field has been that the idiotype vaccine is patient-specific and required the generation of a custo...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744838/ https://ncbi.nlm.nih.gov/pubmed/18422783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2008.07143.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|